Scientists test common bone drug in fight against rare bone cancer
NCT ID NCT03173976
Summary
This early-stage study is testing whether a drug called zoledronic acid, which is normally used to strengthen bones, can help control tumor growth in patients with a type of bone cancer called chondrosarcoma. Participants receive the drug before their standard surgery and again afterward. The main goals are to check if the drug is safe for these patients and to see if it affects the tumor.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHONDROSARCOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Iowa Hospitals and Clinics
Iowa City, Iowa, 52242, United States
Conditions
Explore the condition pages connected to this study.